AcariaHealth Advances Biosimilar Knowledge Through Major Events
AcariaHealth, in collaboration with the National Association of Specialty Pharmacy (NASP) and Reuters Events, has conducted significant educational sessions on biosimilars aimed at enhancing understanding and use in specialty pharmacy.
AcariaHealth, a prominent specialty pharmacy and part of Centene Corporation (NYSE: CNC), has recently concluded three pivotal national events that focused on the advancing landscape of biosimilars in the healthcare field. The notable sessions aimed to equip healthcare professionals with essential tools and insights for biosimilar adoption, overcoming patient access barriers, and enhancing patient outcomes. These gatherings took place in collaboration with NASP, Reuters Events, and included a dedicated webinar led by AcariaHealth.
"Our goal at AcariaHealth is to empower healthcare professionals with the knowledge necessary to confidently incorporate biosimilars into patient care routines," states Jessica Ciccolella-Kahl, CEO of AcariaHealth. The need for education is crucial for improving patient access to safe, effective, and affordable treatment options.
Key Highlights from the Educational Sessions
Throughout these events, participants received invaluable insights into the challenges and opportunities surrounding biosimilar utilization.
NASP Lunch & Learn: Strategies for Thriving with Biosimilars
This session focused on providing foundational education about biosimilars. Kathleen Stenberg, PharmD, CSP and Lead Specialty Pharmacist at AcariaHealth, presented strategies to address common queries from providers and patients, while also discussing how to navigate the complexities of substitution and workflow within specialty pharmacy.
Industry Panel Discussion on Biosimilars in U.S. Healthcare
During this enlightening panel, industry leaders discussed current trends, policy implications, and challenges surrounding biosimilar access. Dr. Stenberg shared insights particularly relevant to specialty pharmacy operations, emphasizing the importance of meeting payer expectations and preparing operational frameworks for biosimilar integration.
AcariaHealth's Commitment to Patient Care
The webinar entitled "Biosimilars in Practice: Maintaining Access and Prioritizing Patient Care" featured a panel of experts, including:
- Alysha Robinson, PharmD, CSP — Director of Specialty Pharmacy Program Management.
- Kathleen Stenberg, PharmD, CSP — Lead Specialty Pharmacist.
- Robin Waida — Director of Physician Sales.
The presentations in this session aimed to dispel common myths about biosimilars and foster understanding among both patients and providers. Participants were equipped with practical strategies to facilitate the successful integration of biosimilars into various care settings.
Key Insights Delivered
The events highlighted several critical takeaways for the healthcare community:
- Awareness of the latest regulatory and market trends affecting biosimilar adoption.
- Effective communication strategies to alleviate hesitancy among providers and patients.
- Comprehensive system-level considerations, including payer dynamics and workflow optimization.
About AcariaHealth
AcariaHealth is dedicated to providing tailored support for patients with complex health conditions through its expertise and personalized care approach. As part of Centene, AcariaHealth is well-positioned to leverage the resources of the largest Medicaid managed care organization, driving transformative health outcomes nationwide.
Frequently Asked Questions
What is the purpose of the educational sessions organized by AcariaHealth?
The sessions aim to educate healthcare professionals about the integration and adoption of biosimilars, improving access and patient care.
Who were the key speakers during the AcariaHealth events?
The events featured experts like Kathleen Stenberg, PharmD, CSP, who provided insights on specialty pharmacy and biosimilar strategies.
What topics were covered in the AcariaHealth sessions?
Topics included biosimilar fundamentals, patient access strategies, and operational readiness within specialty pharmacy.
How can healthcare professionals access recorded sessions?
Recorded sessions are available online for healthcare professionals who want to catch up on the discussions and insights shared.
Why is biosimilar education important for healthcare professionals?
Understanding biosimilars helps providers improve patient access to therapies, reduce costs, and ensure safe treatment options for complex conditions.
